ESGV logoESGV
Vanguard Group, Inc. - Vanguard ESG U.S. Stock ETF

48
Loading...
Loading...
News
all
press releases
Summit Therapeutics Gets A $40 Price Target From Guggenheim: Analyst Says It Likes The Stock At $24, Just Like It Did At $3
The price target of $40 represents an upside of 70% from the stock’s closing price on Wednesday.
Stocktwits·11d ago
News Placeholder
More News
News Placeholder
Is Nuveen ESG Large-Cap Value ETF (NULV) a Strong ETF Right Now?
Zacks·3mo ago
News Placeholder
Is Nuveen ESG Mid-Cap Growth ETF (NUMG) a Strong ETF Right Now?
Zacks·3mo ago
News Placeholder
Is iShares MSCI ACWI Low Carbon Target ETF (CRBN) a Strong ETF Right Now?
Zacks·3mo ago
News Placeholder
Is iShares Paris-Aligned Climate MSCI USA ETF (PABU) a Strong ETF Right Now?
Zacks·4mo ago
News Placeholder
Is iShares ESG Aware MSCI USA ETF (ESGU) a Strong ETF Right Now?
Zacks·4mo ago
News Placeholder
monday.com To Report Q3 As Stock Trades At 3-Year High: Retail Largely Upbeat
monday.com recently hit the financial milestone of $1 million in annual recurring revenue for its “Work” operating system.
Stocktwits·10mo ago

Latest ESGV News

View

Advertisement. Remove ads.

Advertisement. Remove ads.